Abstract
Neonatal herpes simplex virus (HSV) infection is one of the life-threatening infections of newborns. It affects approximately 1,500 to 2,200 infants per year in the United States. Changes in the presentation of neonatal HSV infection over the past two decades include an increase in the frequency of skin, eye, and mouth (SEM) disease with a relatively unchanged rate of central nervous system (CNS) disease, but a relative decline in disseminated infection. Although the mortality of neonatal HSV infections has declined with current antiviral therapy, the mortality rate in CNS disease (15%) and disseminated disease (57%) remains high. Morbidity has been seen most frequently in infants with CNS and disseminated disease, with seizures or infection with HSV-2 determined to be risk factors for poor outcome in survivors. In a multicenter, randomized, blinded study by the Collaborative Antiviral Study Group, no differences in outcome were seen between neonates treated with vidarabine and acyclovir. More recently, administration of oral acyclovir has been demonstrated to prevent cutaneous recurrences of HSV after neonatal SEM disease. Although promising, this investigational protocol requires further evaluation before a routine recommenda...Continue Reading
Citations
Aug 7, 2007·International Journal of Hematology·Eiichi IshiiKeisei Kawa
Jul 6, 2018·Pediatric Dermatology·Christina S ManiceChristine T Lauren
Feb 24, 2001·Cornea·T J Liesegang
Oct 28, 2011·Virology Journal·Ghadah A Karasneh, Deepak Shukla
Aug 1, 2013·Journal of Leukocyte Biology·Lucija SlavicaKristina Eriksson
May 4, 2016·Pharmacotherapy·Jessica M Cottreau, Viktorija O Barr
Jan 20, 2016·The Cochrane Database of Systematic Reviews·Mona NasserMaryam Shahiri Tabarestani
Jul 6, 2000·The Pediatric Infectious Disease Journal·M J Abzug, S M Johnson
Feb 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A Alanen, V Hukkanen
Dec 29, 2007·Ophthalmic Genetics·Hoda Ahmadi, Yasmin S Bradfield
Sep 15, 2000·Infectious Disease Clinics of North America·J D Fingeroth
Mar 6, 2003·Neurologic Clinics·James F Bale
Oct 18, 2007·Journal of the American Academy of Dermatology·Mahnaz Fatahzadeh, Robert A Schwartz